AAPS is hosting an Industry Speaker Seminar next Thursday Jan 23rd at 11:00 am in PHM-1210. Dr. Vanessa Yoon Calvelo, a Research Strategy Development Specialist at UHN will share her “unexpected” career path with us. Refreshments and light snacks will be provided!
We are honoured to have received the AAPS Student Chapter Award for 2022-2023, and are grateful for the dedication of our team and the endless support from the AAPS community. Here's to our continued passion for pharmaceutical sciences! #AAPS#UofT#PharmaceuticalExcellence 💊
We are thrilled to host Chesarahmia Bouhs and Shiron Lee for our next Alumni Seminar Series! Tune in August 8th at 12pm on zoom! https://t.co/0D8Ls6du6M
We're excited to announce our next speaker for our Alumni Seminar Series! Join on us, May 16th @ 1pm via zoom to hear from Dr. Giovanna Schever, an expert on evaluating data for biological oncology drugs, haematological diseases and COVID19. Register here: https://t.co/3lCyz14NS2
Industry Night was a success! The event featured 9 panelists from various industry sectors, including medical affairs, consulting, RND, regulatory affairs and biotech who provided insightful talks about leveraging grad school training to break into the industry. Thank you alumni!
We are thrilled to announce that our Alumni Seminar Series is back! Join us on March 30th at 11am via Zoom to hear from Dr. Lilia Magomedova. Use the meeting QR code or this link to join: https://t.co/i68o6afSIn
The latest from @theaapsjournal: The Biological Effect of Pharmaceutical Excipients
A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development
| MN Martinez @US_FDA |
https://t.co/CSTp2aPIYS
#AAPSJ
The @CityofToronto & @HeritageToronto will commemorate Canada’s first Black doctors – Alexander Augusta & Anderson Abbott – with plaques near #UofT's St. George campus that tell their stories. https://t.co/pBc32qglgV
It’s tomorrow! Our first Alumni Seminar series will take place on Zoom from 12-1. Check out the poster below for more details and get ready for some great science!
#DYK mRNA-based medicines catapulted into the spotlight through their successful use in #COVID#vaccines, yet their potential goes far beyond this application? Review the promise of #mRNA drugs beyond COVID during #NBC2022 this May. Register today: https://t.co/b6f8vCghEk
The AAPS alumni seminar series is back! Join us on March 18th from 12-1 via Zoom to hear from Dr. Charlene Ng. With ample experience from bench to industry, this is a talk you won’t want to miss! Stay tuned for more details. #uoft#aaps
#WomenInScience "need to be champions of their female colleagues because we still have work to do to get the conversations around #DEI converted into real action," advised Nurulain T. Zaveri, PhD, FAAPS in the latest #WIPS spotlight: https://t.co/viebMiJwUm
#WomenInSTEM
#DYK that thousands of scientists have been displaced around the world in recent years? AAPS' publishing partner, @SpringerNature, teamed with @CARA1933 to fund fellowship awards to support academics who cannot continue their work in their home countries. https://t.co/I9LYApuReH
📢 The latest from @pharmscitech: "Researchers... have shown a promising method for the delivery of #curcumin. The successful therapeutic delivery of curcumin could also be a treatment for #COVID19."
https://t.co/yUwpziltA9
#DYK#CardiovascularProfessionalsWeek is this month? AAPS will focus this month on research related to #heartdisease and heart health. From @theaapsjournal, read "Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling."
https://t.co/5GzIAWyHdE
The latest from @theaapsjournal: Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells
| Devika S. Manickam, Duquesne University @duqedu, USA |
https://t.co/R8zux1JpOn
#siRNA#nanoparticle#LNP#AAPSJ
#DYK that it's #CervicalCancerAwarenessMonth? This month, AAPS will focus on medical research related to women’s health. From @theaapsjournal, read the research in "Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics:" https://t.co/17BAwtohlH